How Farxiga Helps a Failing Heart

More Heart Disease, Stroke and Diabetes Articles

How Farxiga Helps a Failing Heart

By Your Health Magazine Health Information Team

You become short of breath climbing stairs, your ankles swell by evening, and your cardiologist prescribes Farxiga—even though you do not have diabetes. Why would a medicine originally developed to lower blood sugar help a failing heart?

The short answer is that Farxiga helps the kidneys remove glucose, sodium, and fluid from the body. This can reduce congestion and ease some of the workload placed on the heart. More importantly, research shows that it lowers the risk of worsening heart failure, hospitalization, urgent heart failure visits, and cardiovascular death in appropriate adults. These benefits can occur whether or not a person has type 2 diabetes.

What Does Farxiga Do for Heart Failure?

Farxiga is the brand name for dapagliflozin, a medication in the sodium-glucose cotransporter 2, or SGLT2, inhibitor class. It works primarily in the kidneys, where it blocks some of the glucose and sodium that would normally be returned to the bloodstream. These substances leave the body through urine instead.

Because water follows glucose and sodium, people may urinate more and retain less excess fluid. For someone with heart failure, reducing fluid buildup may help decrease pressure inside the heart and blood vessels. This can potentially make breathing and physical activity easier, although individual symptom improvement varies.

Farxiga does not directly force the heart to beat harder, and it is not a rescue treatment for sudden breathing difficulty. Its longer-term purpose is to reduce the likelihood of serious heart failure complications. The precise reasons SGLT2 inhibitors protect the heart are still being studied and likely involve several effects on fluid balance, kidney function, circulation, and metabolism.

Why Removing Extra Fluid Matters

Heart failure means the heart cannot pump or fill as effectively as the body needs. It does not mean that the heart has stopped. When circulation becomes less efficient, the kidneys may retain sodium and water. Fluid can then collect in the lungs, legs, ankles, or abdomen.

This congestion may cause:

• Shortness of breath during activity or while lying flat
• Swelling in the feet, ankles, legs, or abdomen
• Rapid weight gain related to fluid retention
• Fatigue, weakness, or reduced exercise tolerance
• Coughing or waking at night feeling breathless

By changing how the kidneys handle glucose and sodium, Farxiga may help reduce this cycle of fluid accumulation. It has a mild diuretic effect, but it is not identical to traditional “water pills” such as loop diuretics. Some people with heart failure need both types of medication because they work differently.

Benefits With and Without Diabetes

One common misconception is that Farxiga helps the heart only by lowering blood sugar. Large clinical trials found benefits among people with heart failure both with and without type 2 diabetes. That finding changed how healthcare professionals use SGLT2 inhibitors in cardiovascular care.

Farxiga has been studied in heart failure with reduced ejection fraction, in which the heart’s main pumping chamber does not squeeze strongly enough. It has also been studied in people with mildly reduced or preserved ejection fraction, where the heart may squeeze relatively normally but has difficulty relaxing and filling.

Across these forms of heart failure, dapagliflozin reduced the combined risk of cardiovascular death and worsening heart failure events. This does not mean every person will feel dramatically different or avoid every hospitalization. It means that, across groups of appropriately selected patients, serious events occurred less often among those receiving the medication.

How Farxiga Fits Into a Heart Failure Plan

Heart failure usually requires several treatments because no single medication addresses every cause or effect of the condition. Farxiga is commonly added to other guideline-directed therapies rather than used as a replacement for them.

A care plan may also include medications that lower blood pressure, slow the heart rate, relax blood vessels, reduce harmful hormonal signals, or remove larger amounts of excess fluid. Nutrition, appropriate physical activity, symptom tracking, and management of conditions such as high blood pressure, kidney disease, coronary artery disease, and diabetes are also important.

People should not stop or change heart failure medications because swelling or breathing temporarily improves. Heart failure benefits often depend on continuing a coordinated treatment plan under medical supervision.

What You May Notice in Everyday Life

Some people notice more frequent urination after beginning Farxiga. Blood pressure may decrease, and dizziness can occur, especially when standing up. A healthcare professional may monitor kidney function, blood pressure, hydration, and other medications, particularly if the person already takes a diuretic.

Changes on the scale may reflect loss of fluid, and dapagliflozin can also cause some calorie loss through glucose in the urine. However, Farxiga is not primarily a weight-loss medication when prescribed for heart failure. Readers interested in this separate issue can learn more about what to expect regarding weight loss with Farxiga.

People with heart failure are often advised to track their weight and symptoms at home. Sudden weight changes can signal shifting fluid levels rather than changes in body fat, so unexplained gains or losses should be discussed with the care team.

Side Effects and Important Precautions

Farxiga can cause genital yeast infections and urinary symptoms because additional glucose passes into the urine. It may also contribute to dehydration, low blood pressure, or temporary changes in kidney laboratory results. The risk of low blood sugar is generally greater when it is combined with insulin or certain other diabetes medicines.

A rare but serious complication is ketoacidosis, an abnormal buildup of acids called ketones. It can sometimes occur even when blood glucose is not extremely high. Warning signs may include nausea, vomiting, abdominal pain, unusual fatigue, or difficulty breathing. Illness, prolonged fasting, surgery, dehydration, heavy alcohol use, and very-low-carbohydrate diets may increase risk in susceptible people.

Before treatment, the prescriber should know about kidney or liver problems, low blood pressure, recurrent urinary or genital infections, pancreatic disease, pregnancy, breastfeeding, planned surgery, and all medications and supplements being used. General medication safety information is available through MedlinePlus drug information resources.

When to Seek Care

Contact a cardiologist, primary care clinician, or heart failure care team promptly for increasing swelling, rapid fluid-related weight gain, worsening fatigue, new dizziness, painful urination, fever, genital irritation, or a noticeable decline in normal activity tolerance.

Seek emergency care for severe or sudden shortness of breath, chest pain, fainting, confusion, blue or gray lips, coughing up pink or foamy mucus, or difficulty breathing at rest. Immediate evaluation is also appropriate for symptoms suggesting ketoacidosis or a severe infection, including persistent vomiting, abdominal pain, rapid breathing, or painful redness and swelling around the genital or anal area.

The Bottom Line

So, what does Farxiga do for heart failure? It changes how the kidneys handle glucose, sodium, and water, helping reduce fluid-related stress while providing broader heart and kidney benefits. In suitable adults, it can lower the risk of worsening heart failure, urgent visits, hospitalization, and cardiovascular death—even when diabetes is not present.

Farxiga does not cure heart failure and is not appropriate for everyone. Its value comes from being one part of a carefully managed treatment plan based on heart function, kidney health, blood pressure, symptoms, and other medications.